ArticleHuman vaccines & immunotherapeutics2024

Long-term immunogenicity of the SA14-14-2 Japanese encephalitis (JE) vaccine (CD.JEVAX®) booster following chimeric JE (IMOJEV®) vaccine priming in Thai children.

Tawee Chotpitayasunondh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.